Literature DB >> 20087158

Use of fluorescence in situ hybridization (FISH) to distinguish intranodal nevus from metastatic melanoma.

Scott R Dalton1, Pedram Gerami, Nicholas A Kolaitis, Susan Charzan, Rob Werling, Philip E LeBoit, Boris C Bastian.   

Abstract

With the increase in sentinel lymph node biopsies in melanoma patients, pathologists are frequently confronted with small deposits of morphologically bland melanocytes in the node, which occasionally cannot be readily classified as benign nodal nevi or melanoma. As most melanomas harbor characteristic chromosomal aberrations which can be used to distinguish them from benign nevi, we used fluorescence in-situ hybridization (FISH) with markers for 3 regions on chromosome 6 and 1 on chromosome 11 to determine the presence of chromosomal aberrations in sentinel lymph node specimens with small foci of melanocytes that had been diagnosed as metastatic melanoma or nodal nevi by histopathology. Fifty-nine tissue samples from 41 patients (24 lymph node metastases, 17 with nodal nevi, and 18 of the available corresponding primary melanomas) were analyzed by FISH. Twenty of 24 (83%) cases diagnosed as metastatic melanoma showed aberrations by FISH. Of the 4 negative cases, 3 were unequivocal melanoma metastases, whereas 1 on re-review was histopathologically equivocal. Of the 17 nodal nevi, 1 (6%) also showed aberrations by FISH, whereas the remainder was negative. Multiple aberrations were present in the positive case, some of which were also found in the corresponding primary tumor, suggesting that this case represents a deceptively bland melanoma metastasis that had been misclassified by histomorphology. Our data indicate that FISH is a useful adjunct tool to traditional methods in the diagnostic workup of deposits of melanocytes in lymph nodes that are histopathologically ambiguous.

Entities:  

Mesh:

Year:  2010        PMID: 20087158      PMCID: PMC2831773          DOI: 10.1097/PAS.0b013e3181c805c4

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  16 in total

1.  Fluorescence in situ hybridization (FISH) as an ancillary diagnostic tool in the diagnosis of melanoma.

Authors:  Pedram Gerami; Susan S Jewell; Larry E Morrison; Beth Blondin; John Schulz; Teresa Ruffalo; Paul Matushek; Mona Legator; Kristine Jacobson; Scott R Dalton; Susan Charzan; Nicholas A Kolaitis; Joan Guitart; Terakeith Lertsbarapa; Susan Boone; Philip E LeBoit; Boris C Bastian
Journal:  Am J Surg Pathol       Date:  2009-08       Impact factor: 6.394

2.  Chromosomal gains and losses in primary cutaneous melanomas detected by comparative genomic hybridization.

Authors:  B C Bastian; P E LeBoit; H Hamm; E B Bröcker; D Pinkel
Journal:  Cancer Res       Date:  1998-05-15       Impact factor: 12.701

3.  A micromorphometry-based concept for routine classification of sentinel lymph node metastases and its clinical relevance for patients with melanoma.

Authors:  H Starz; B R Balda; K U Krämer; H Büchels; H Wang
Journal:  Cancer       Date:  2001-06-01       Impact factor: 6.860

4.  Sentinel-node biopsy or nodal observation in melanoma.

Authors:  Donald L Morton; John F Thompson; Alistair J Cochran; Nicola Mozzillo; Robert Elashoff; Richard Essner; Omgo E Nieweg; Daniel F Roses; Harald J Hoekstra; Constantine P Karakousis; Douglas S Reintgen; Brendon J Coventry; Edwin C Glass; He-Jing Wang
Journal:  N Engl J Med       Date:  2006-09-28       Impact factor: 91.245

5.  Nodal nevi and cutaneous melanomas.

Authors:  K F Carson; D R Wen; P X Li; A M Lana; C Bailly; D L Morton; A J Cochran
Journal:  Am J Surg Pathol       Date:  1996-07       Impact factor: 6.394

Review 6.  Pathology of the lymph nodes in patients with malignant melanoma.

Authors:  A J Cochran; M E Robert; D R Wen
Journal:  Pathology (Phila)       Date:  1994

7.  Sentinel lymph nodes in malignant melanoma: extended histopathologic evaluation improves diagnostic precision.

Authors:  Helene Nortvig Abrahamsen; Stephen J Hamilton-Dutoit; Jørn Larsen; Torben Steiniche
Journal:  Cancer       Date:  2004-04-15       Impact factor: 6.860

8.  The microanatomic location of metastatic melanoma in sentinel lymph nodes predicts nonsentinel lymph node involvement.

Authors:  D J Dewar; B Newell; M A Green; A P Topping; B W E M Powell; M G Cook
Journal:  J Clin Oncol       Date:  2004-08-15       Impact factor: 44.544

9.  Expression of melanocyte differentiation antigens and ki-67 in nodal nevi and comparison of ki-67 expression with metastatic melanoma.

Authors:  Christina M Lohmann; Kirsten Iversen; Achim A Jungbluth; Marianne Berwick; Klaus J Busam
Journal:  Am J Surg Pathol       Date:  2002-10       Impact factor: 6.394

10.  Distribution and significance of occult intraepidermal tumor cells surrounding primary melanoma.

Authors:  Jeffrey P North; Toshiro Kageshita; Daniel Pinkel; Philip E LeBoit; Boris C Bastian
Journal:  J Invest Dermatol       Date:  2008-03-06       Impact factor: 8.551

View more
  10 in total

1.  Assessment of copy number status of chromosomes 6 and 11 by FISH provides independent prognostic information in primary melanoma.

Authors:  Jeffrey P North; John T Vetto; Rajmohan Murali; Kevin P White; Clifton R White; Boris C Bastian
Journal:  Am J Surg Pathol       Date:  2011-08       Impact factor: 6.394

2.  Comparison between melanoma gene expression score and fluorescence in situ hybridization for the classification of melanocytic lesions.

Authors:  Eugen C Minca; Rami N Al-Rohil; Min Wang; Paul W Harms; Jennifer S Ko; Angela M Collie; Ivanka Kovalyshyn; Victor G Prieto; Michael T Tetzlaff; Steven D Billings; Aleodor A Andea
Journal:  Mod Pathol       Date:  2016-05-13       Impact factor: 7.842

3.  Correlating array comparative genomic hybridization findings with histology and outcome in spitzoid melanocytic neoplasms.

Authors:  Liaqat Ali; Thomas Helm; Richard Cheney; Jeffrey Conroy; Sheilla Sait; Joan Guitart; Pedram Gerami
Journal:  Int J Clin Exp Pathol       Date:  2010-06-28

Review 4.  Review of diagnostic, prognostic, and predictive biomarkers in melanoma.

Authors:  Jacob S Ankeny; Brian Labadie; Jason Luke; Eddy Hsueh; Jane Messina; Jonathan S Zager
Journal:  Clin Exp Metastasis       Date:  2018-05-02       Impact factor: 5.150

Review 5.  Through the looking glass and what you find there: making sense of comparative genomic hybridization and fluorescence in situ hybridization for melanoma diagnosis.

Authors:  Jayson Miedema; Aleodor A Andea
Journal:  Mod Pathol       Date:  2020-02-17       Impact factor: 7.842

Review 6.  From melanocytes to melanomas.

Authors:  A Hunter Shain; Boris C Bastian
Journal:  Nat Rev Cancer       Date:  2016-04-29       Impact factor: 60.716

Review 7.  Diagnostic and prognostic biomarkers in melanoma.

Authors:  David Weinstein; Jennifer Leininger; Carl Hamby; Bijan Safai
Journal:  J Clin Aesthet Dermatol       Date:  2014-06

8.  Novel computational method for predicting polytherapy switching strategies to overcome tumor heterogeneity and evolution.

Authors:  Vanessa D Jonsson; Collin M Blakely; Luping Lin; Saurabh Asthana; Nikolai Matni; Victor Olivas; Evangelos Pazarentzos; Matthew A Gubens; Boris C Bastian; Barry S Taylor; John C Doyle; Trever G Bivona
Journal:  Sci Rep       Date:  2017-03-13       Impact factor: 4.379

9.  5-Hydroxymethylcytosine expression in metastatic melanoma versus nodal nevus in sentinel lymph node biopsies.

Authors:  Jonathan J Lee; Scott R Granter; Alvaro C Laga; Arturo P Saavedra; Qian Zhan; Weimin Guo; Shuyun Xu; George F Murphy; Christine G Lian
Journal:  Mod Pathol       Date:  2014-08-01       Impact factor: 7.842

10.  Four-color fluorescence in-situ hybridization is useful to assist to distinguish early stage acral and cutaneous melanomas from dysplastic junctional or compound nevus.

Authors:  Yumei Lai; Yan Wu; Ruping Liu; Aiping Lu; Lixin Zhou; Lin Jia; Xinting Diao; Zhongwu Li
Journal:  Diagn Pathol       Date:  2020-05-11       Impact factor: 2.644

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.